I am a
Home I AM A Search Login

Papers of the Week

2020 Feb 01

Drug Alcohol Depend


Determinants of selection into buprenorphine/naloxone among people initiating opioid agonist treatment in British Columbia.


Homayra F, Hongdilokkul N, Piske M, Pearce LA, Zhou H, Min JE, Krebs E, Nosyk B
Drug Alcohol Depend. 2020 Feb 01; 207:107798.
PMID: 31927163.


Studies assessing the comparative effectiveness of methadone versus buprenorphine/naloxone for opioid use disorder in real-world settings are rare – challenged by structural differences in delivery across settings and factors influencing treatment selection. We identified determinants of selection into buprenorphine/naloxone and quantified contributions of individual and provider-level covariates in a setting delivering both medications within the same healthcare settings.